Fitlife Brands, Inc. (FTLF): Operating Income
$10.06M
Year ended 2025-12-31
$11.00M
Trailing 12 months to 2026-06-30
+20.8%
3-year compound annual growth
+18.3%
5-year compound annual growth
| Period ended | Operating Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.06M | -23.3% | 2026-03-31, From 2025-01-01 |
| 2024-12-31 | $13.12M | +73.8% | 2026-03-31, From 2024-01-01 |
| 2023-12-31 | $7.55M | +32.4% | 2025-03-27, From 2023-01-01 |
| 2022-12-31 | $5.70M | -8.5% | 2024-03-29, From 2022-01-01 |
| 2021-12-31 | $6.23M | +43.4% | 2023-03-24, From 2021-01-01 |
| 2020-12-31 | $4.35M | +74.3% | 2022-10-13, From 2020-01-01 |
| 2019-12-31 | $2.49M | n/c | 2022-10-13, From 2019-01-01 |
| 2018-12-31 | $653.0K | n/m | 2020-03-30, From 2018-01-01 |
| 2017-12-31 | -$8.95M | n/m | 2019-03-22, From 2017-01-01 |
| 2016-12-31 | $472.3K | n/m | 2018-04-17, From 2016-01-01 |
| 2015-12-31 | -$1.09M | n/m | 2017-04-17, From 2015-01-01 |
| 2014-12-31 | $1.85M | +33.5% | 2016-04-14, From 2014-01-01 |
| 2013-12-31 | $1.39M | -26.2% | 2015-03-31, From 2013-01-01 |
| 2012-12-31 | $1.88M | +801.6% | 2014-03-28, From 2012-01-01 |
| 2011-12-31 | $208.7K | n/m | 2013-04-01, From 2011-01-01 |
| 2010-12-31 | -$3.10M | n/a | 2012-04-13, From 2010-01-01 |
Operating Income at similar companies
| Company | Year ended | Operating Income | Change YoY |
|---|---|---|---|
| Fitlife Brands, Inc. (FTLF) | 2025-12-31 | $10.06M | -23.3% |
| Mannatech Inc (MTEX) | 2025-12-31 | -$426.0K | n/m |
| Niagen Bioscience, Inc. (NAGE) | 2025-12-31 | $16.28M | +110.7% |
| Natural Alternatives International Inc (NAII) | 2026-06-30 | -$18.75M | n/m |
| Cronos Group Inc. (CRON) | 2025-12-31 | -$17.39M | n/m |
| Marimed Inc. (MRMD) | 2025-12-31 | -$2.82M | n/m |
| Glass House Brands Inc. (GLAS) | 2025-12-31 | -$16.53M | n/m |
| Leef Brands Inc. (LEEEF) | 2025-12-31 | -$7.59M | n/m |
| biote Corp. (BTMD) | 2025-12-31 | $35.55M | +12.5% |
Compare FTLF, MTEX, NAGE, NAII side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗